The role of TNF-α in human adipose tissue: Prevention of weight gain at the expense of insulin resistance?

Hormone and Metabolic Research

Volumn 31, Issue 12, 1999, Pages 626-631

  Hube, F ^a   Hauner, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adipose Differentiation; Human Adipose Tissue; Insulin Resistance; Obesity; Tumor Necrosis Factor

Indexed keywords

GLYCEROL 3 PHOSPHATE DEHYDROGENASE; PEROXISOME PROLIFERATOR; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BODY FAT; CELL DIFFERENTIATION; ENZYME ACTIVITY; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIPOLYSIS; MEDIATOR RELEASE; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; WEIGHT GAIN;

ANIMALIA;

EID: 0033393956     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978810     Document Type: Review

References (67)

1. 1 Carswell EA, Old J, Kassel RL. Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necroses of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670
2. 2 Kawakami M, Pekala PH, Lane DM, Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA 1982; 79: 912-916
3. 3 Beutler B, Greenwald D, Hulmes JD, Chang M, Pan Y-C, Mathison J, Ulevitch R, Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316: 552-554
4. 4 Aggarwal BB, Natarajan K. Tumor necrosis factors: developments in the last decade. Eur Cytokine Netw 1996; 7: 93-124
5. 5 Spriggs DR, Deutsch S, Kufe DW. Genomic structure, induction, and production of TNF-alpha. Immunol Ser 1992; 56: 3-34
6. 6 Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86
7. 7 Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/ cachectin is a cell surface cytotoxic transmembrane protein; ramifications for the complex physiology of TNF. Cell 1988; 53: 45-53
8. 8 Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R. Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385: 729-733
9. 9 Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994; 76: 959-962
10. 10 Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi M, Lesslauer W. Molecular cloning and expression of the human 55 kDa tumor necrosis factor receptor. Cell 1990; 61: 351-359
11. 11 Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG. A receptor for human tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248: 1019-1023
12. 12 Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802
13. 13 Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM. A metalloproteinase inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 1995; 155: 5198-5205
14. 14 Porteau F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 1994; 269: 2834-2840
15. 15 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91
16. 16 Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue, regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119
17. 17 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415
18. 18 Hube F. Birgel M, Lee Y-M, Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999; 29: 672-678
19. 19 Hube F, Lee Y-M, Röhrig K, Hauner H. The phosphodiesterase inhibitor IBMX suppresses TNF-α expression in human adipocyte precursor cells: a possible explanation for its adipogenic effect. Horm Metab Res 1999; 31: 359-362
20. 20 Morin CL, Eckel RH, Marcel T, Pagliassotti MJ. High fat diets elevate tissue-derived tumor necrosis factor-α activity. Endocrinology 1997; 138: 4665-4671
21. 21 Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274: 1377-1379
22. 22 Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997; 46: 451-455
23. 23 Kellerer M, Rett K, Groop L, Häring HU. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996; 28: 737-743
24. 24 Hauner H, Bender M, Haastert B, Hube F. Plasma concentrations of TNF-α and its soluble receptors in obese subjects. Int J Obesity 1998; 22: 1239-1243
25. 25 Pfeiffer A, Janott J, Möhlig M, Ristow M, Rochlitz H, Busch K, Schatz H, Schifferdecker E. Circulating tumor necrosis factor α is elevated in male but not in female patients with type II diabetes mellitus. Horm Metab Res 1997; 29: 111-114
26. 26 Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200
27. 27 Semb H, Peterson J, Tavernier J, Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 1987; 262: 8390-8394
28. 28 Cornelius P, Enerback S, Bjursell G, Olivecrona T, Pekala PH. Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumor necrosis factor. Biochem J 1988; 249: 765-769
29. 29 Fried SK, Zechner R. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res 1989; 30: 1917-1923
30. 30 Torti FM, Torti SV, Larrick JW, Ringold GM. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor β. J Cell Biol 1989; 108: 1105-1113
31. 31 Stephens JM, Pekala PH. Transcriptional repression of Glut-4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor alpha. J Biol Chem 1992; 266: 21839-21845
32. 32 Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM. TNF-alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology 1997; 138: 2776-2783
33. 33 MacDougald OA, Lane D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995; 64: 345-373
34. 34 Ogawa H, Nielsen S, Kawakami M. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase and intracellular lipolysis in 3T3-L1 cells. Biochim Biophys Acta 1989; 1003: 131-135
35. 35 Hauner H, Petruschke T, Russ M, Röhrig K, Eckel J. Effects of tumour necrosis factor alpha (TNF) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 1995; 38: 764-771
36. 36 Orban Z, Remaley AT, Sampson M, Trajanoski Z, Chrousos GP. The differential effect of food intake and β-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 1999; 84: 2126-2133
37. 37 Pekala PH, Kawakami M, Angus CW, Lane MD, Cerami A. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci 1983; 80: 2743-2747
38. 38 Petruschke T, Hauner H. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 1993; 76: 742-747
39. 39 Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-26058
40. 40 Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci 1994; 91: 4854-4858
41. 41 Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor α-induced phosphorylation of insulin receptor substrate-1 (IRS1). J Biol Chem 1995; 270: 23780-23784
42. 42 Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 1996; 271: 665-668
43. 43 Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A, Berti L, Horikoshi H, Ullrich A, Häring H. Tumor necrosis factor-α-and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 1996; 97: 1471-1477
44. 44 Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997; 272: 971-976
45. 45 Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996; 271: 13018-13022
46. 46 Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced thyrosine phosphorylation. J Biol Chem 1997; 272: 29911-29918
47. 47 Valverde AM, Teruel T, Navarro P, Benito M, Lorenzo M. Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinology 1998; 139: 1229-1238
48. 48 Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes. Implication of the p80 tumor necrosis factor receptor. Diabetes 1998; 47: 515-522
49. 49 Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996; 45: 881-885
50. 50 Kanety H, Hemi R, Papa MZ, Karasik A. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem 1996; 271: 9895-9897
51. 51 Wang C-N, O'Brien L, Brindley DN. Effects of cell-permeable ceramides and tumor necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes 1998; 47: 24-31
52. 52 Schreyer SA, Streamson CC, LeBoeuf RC. Obesity and diabetes in TNF-α receptor-deficient mice. J Clin Invest 1998; 102: 402-441
53. 53 Uysal KT, Wiesbrock SM, Hotamisligil GS. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity. Endocrinology 1998; 139: 4832-4838
54. 54 Sethi JK, Xu H, Uysal KT, Wiesbrock SM, Scheja L, Hotamisligil GS. Establishment and characterization of preadipocyte cell lines fromTNFR1, TNFR2 and TNFR1&2 knockout mice. J Interferon Cytokine Res 1998; 18: A-110
55. 55 Hauner H, Lee Y-M, Röhrig K, Hube F. Do the TNF receptors mediate different effects in human adipose tissue? Obes Res 1997; 5 Suppl 1:17S
56. 56 Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistence in mice lacking TNF-alpha function. Nature 1997; 389: 610-614
57. 57 Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJJR, Hotamisligil GS, Spiegelman BM. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994; 134: 264-270
58. 58 Szalkowski D, White-Carrington S, Berger J, Zhang B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3 L1 cells. Endocrinology 1996; 136: 1474-1481
59. 59 Peraldi P, Xu M, Spiegelman BM. Thiazolidindiones block tumor necrosis factor-α-induced inhibition of insulin signaling. J Clin Invest 1997; 100: 1863-1869
60. 60 Miles DC, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM. TNF-α-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 1997; 46; 1678-1683
61. 61 Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: Strategies to restrain this proinflammatory cytokine. Immunol Today 1997; 18: 487-492
62. 62 Crunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97: 2152-2157
63. 63 Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100: 2777-2782
64. 64 Friedman JM, Haiaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770
65. 65 Zumbach MS, Boehme MWJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997; 82: 4080-4082
66. 66 Gottschling-Zeller H, Birgel M, Scriba D, Blum WF, Hauner H. Depot-specific release of leptin from subcutaneous and omental adiocytes in suspension culture: effect of tumor necrosis factor-α and transforming growth factor-β1. Eur J Endocrinol 1999; 141: 436-442
67. 67 Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O'Rahilly S, Walker N, Cameron DP. Tumor necrosis factor-α induces apoptosis of human adipose cells. Diabetes 1997; 46: 1939-1944